ReviewTranslational sports medicine2025
Meniscal Tear Repair: What's New in the Literature?
Review in Translational sports medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Meniscal tear repair has become the gold standard modality for treating different types of meniscal tears. Despite the availability of numerous repair techniques, the ideal approach remains unclear, especially for complex and irreparable tears. Recently, innovative techniques have emerged to address these challenges, including hybrid/salvage techniques, meniscal scaffolds, and the introduction of biologics as part of the treatment. However, to date, no comprehensive review has provided an overview of the latter adjuncts to surgical intervention and aid in the management of irreparable meniscal tears. This study aims to fill this gap by examining the most common meniscal tear repair techniques, with a particular emphasis on the latest advancements in hybrid and salvage strategies. In addition, we will explore the role of biologics, including platelet-rich plasma and stem cells, in enhancing repair outcomes and assisting less experienced surgeons in treating complex, irreparable tears.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.